ArticleClinical and translational radiation oncology2026
Comment on "Deep learning in CT-based organ-at-risk delineation for pediatric flank irradiation": Methodological and clinical considerations.
Article in Clinical and translational radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The study by Ding et al. on deep-learning-assisted organ-at-risk delineation for pediatric flank irradiation offers a valuable advancement toward automation in radiotherapy planning. However, several methodological and analytical gaps limit the confidence with which these findings can be generalized. Key issues include insufficient transparency of the manual annotation protocol and absence of baseline inter-observer variability metrics; possible circularity from using STAPLE consensus incorporating deep-learning contours; reliance solely on geometric similarity indices (Dice, HD95) without accompanying dosimetric validation; lack of uncertainty quantification or failure-mode analysis; and omission of workflow assessments beyond controlled settings. Together, these constraints obscure the true clinical impact of deep learning in radiotherapy contouring. Future investigations should prioritize transparent multicenter annotation standards, integrate probabilistic or uncertainty-aware models, include dosimetric endpoints, and evaluate performance within real-world clinical environments. Such measures will ensure that the promise of AI-assisted contouring translates into reproducible, safe, and clinically meaningful improvements in pediatric radiotherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.